ITLN1 is preferentially produced by stromovascular cells in VAT31 but has also been identified in human epicardial fat cells, mesothelial cells, airway goblet cells, and cells lining the gut and ovaries.32 A series of studies have linked raised levels of ITLN1 to various cancers.33, 34, 35, 36, 37, 38, 39, 40 ITLN1 has been suggested to promote cancer cell growth by triggering genomic instability via phosphatidylinositol‐3 kinase downstream effector signalling pathways.41 The role of ITLN1 in CC however, has not been well characterised. Here, ITLN1 is linked to cancer.